Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases
A Babazadeh, FM Vahed, SM Jafari - Journal of Controlled Release, 2020 - Elsevier
The treatment for brain disorders specifically neurodegenerative diseases (NDDs) has been
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases.
A Babazadeh, SM Jafari - Journal of Controlled Release: Official …, 2020 - europepmc.org
The treatment for brain disorders specifically neurodegenerative diseases (NDDs) has been
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases
A Babazadeh, FM Vahed… - Journal of controlled …, 2020 - pubmed.ncbi.nlm.nih.gov
The treatment for brain disorders specifically neurodegenerative diseases (NDDs) has been
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases
A Babazadeh, FM Vahed… - Journal of Controlled …, 2020 - researchers.mq.edu.au
The treatment for brain disorders specifically neurodegenerative diseases (NDDs) has been
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …
a main challenge in the medical field. NDDs are progressive, disabling, and non-curable …